Global Glucose Biosensor Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global glucose biosensor Market in its upcoming report titled, “Global Glucose Biosensor Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global glucose biosensor market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global glucose biosensor market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global glucose biosensor market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global glucose biosensor drug market report has been segmented on the basis on type, application, use, and region.

Request Covid - 19 Impact

The biosensor also known as biological sensor and is basically an analytical tool which consists of three main parts, the biological recognition element-help in segregating target molecules such as enzymes, antibody, DNA and cell in presence of various chemicals, transducer-convert bio recognition event such as ph change, heat, light and mass changes into signals which are measured in transducer part and signal processing system-convert signals into readings.  A glucose biosensor aids in monitoring blood glucose level in diabetic patients which in turn aids in managing and controlling diabetes and avoid any further complications. These sensors convert biological response into an electrical signal and aid in measuring a wide spectrum of analysts together with bacteria, grasses, organic compounds and others. Glucose measurements are based on interactions with one of three enzymes namely hexokinase, glucose oxidase (GOx) or glucose-1-dehydrogenase (GDH). The glucose biosensors eliminate the use of invasive measures to check for diabetes that are currently available in the market.

According to international diabetic federation(IDF) in 2017, approximately 425 million adults have diabetes; by 2045 this is anticipated to grow to 629 million. Glucose biosensors have evolved to be more reliable, rapid, and accurate and are also more compact and easy to use devices. Increasing number of diabetes incidences across the globe as diabetic patients require continuous glucose monitoring for effective disease management, thereby increasing demand of glucose biosensors. In addition, growing demand of non-invasive products, in home diagnosis and increasing awareness about early detection and prevention of diabetes are anticipated to drive the  growth of glucose biosensor market globally.

Increasing competition, availability of alternatives for diabetes management especially in the developing regions and lack of standardization and knowledge are anticipated to inhibit the growth of the glucose biosensors market.

Alternate site testing methods use blood drops from places other than the finger, usually the palm or forearm for pain free practice. Glucose meters eliminates the use of invasive measures and is the single largest selling biosensor product around the world due to ease of use. Downloadable meters are most newer systems that allows the user to download meter present results, as well as past, to a computer for further analyses. Wearable sensors such as glucowatch which adhere to the surface of the skin maximizing the use and reliability of the sensor. Complementary metal oxide semiconductor (CMOS) image sensors are increasingly becoming strong bio sensing tool owing to various benefits such as low power consumption, compact size and high strength of signal are the new trends in glucose biosensor market.

The global glucose biosensor market report has been segmented on the basis of type, application, use, and region. On the basis of region, the global anti-obesity prescription drug market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among all the regions, the glucose biosensor market in North America dominates the market with the largest share as diabetes is the leading causes of illness and death in the U.S. region are key factors attributing to accelerated regional market growth. The glucose biosensor market in Asia-pacific is expected to grow rapidly primarily due to increasing prevalence of diabetes in China and India.

Market Segmentation:

Global glucose biosensor market segmentation by type:

• Electrochemical Biosensors
• Piezoelectric Biosensors
• Optical Biosensors
• Thermal Biosensors
• Nanomechanical Biosensors
• Others (including Immuno–Biosensors, Conduct Metric Biosensor, Amperometric Biosensor etc)

Global glucose biosensor market segmentation by application:

• Point of Care
• Home Diagnostics
• Research Labs
• Biodefense
• Food & Beverages Industry

Global glucose biosensor market segmentation by use:

• Single Use
• Intermittent Use
• Continuous (In Vivo) Sensors

Global glucose biosensor market segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Roche AG.
• Bayer AG.
• Life Scan Inc.
• Abbott Laboratories, Limited.
• Siemens AG.
• Medtronic Inc.
• Nova Biomedical Corp.
• Sysmex Corporation
• Biosensors International Group.
• Lifesensors Inc.
• Universal Biosensors.